KE-QIN HU, MD
Osteopathic Medicine at The City Dr, Orange, CA
License number
California 000000A62017
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
2
101 The City Dr SOUTH, Orange, CA 92868
PO Box 54509, Los Angeles, CA 90054
PO Box 54509, Los Angeles, CA 90054
Phone
(714) 456-8978
(714) 456-6369
(714) 456-6369
Organization information
See more information about KE-QIN HU at bizstanding.comKe-Qin Hu MD
101 The City Dr S, Orange, CA 92868
Industry:
Gastroenterology, Internist
Site:
Phone:
(888) 717-4463 (Phone)
Description:
There are 2 doctors at this site. Surgery is not performed at this site.
Ke-Qin Hu
Professional information
Ke-Qin Hu, Orange CA
Specialties:
Internist
Address:
101 The City Dr S, Orange, CA 92868
Education:
Tongji Medical University - Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*
Dr. Ke-Qin Hu, Orange CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Comp Digestive Disease Ctr
101 The City Dr S STE 22C, Orange 92868
(888) 717-4463 (Phone)
101 The City Dr S STE 22C, Orange 92868
(888) 717-4463 (Phone)
Certifications:
Internal Medicine, 2008
Awards:
Healthgrades Honor Roll
Languages:
English, Chinese
Hospitals:
Comp Digestive Disease Ctr
101 The City Dr S STE 22C, Orange 92868
UC Irvine Health
101 The City Dr South, Orange 92868
101 The City Dr S STE 22C, Orange 92868
UC Irvine Health
101 The City Dr South, Orange 92868
Education:
Medical School
Tongji Med U
Huntington Memorial Hospital
University Of Southern California School Of Medicine
Tongji Med U
Huntington Memorial Hospital
University Of Southern California School Of Medicine
Direct Detection Of Hepatitis C Virus Rna
US Patent:
5914228, Jun 22, 1999
Filed:
Nov 8, 1994
Appl. No.:
8/335595
Inventors:
John M. Vierling - Beverly Hills CA
Ke-Qin Hu - Los Angeles CA
Ke-Qin Hu - Los Angeles CA
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
C12Q 170, C12Q 168, C12P 1934, C07H 2104
US Classification:
435 5
Abstract:
The methods and compositions of this invention provide a fast, accurate means for directly determining the presence and quantity of HCV in a sample, and thus in a patient, through hybridization to patient samples using a probe specific for HCV. They allow detection of both acute and chronic HCV infection. These methods and compositions also allow for the effective monitoring of therapeutic procedures for treating HCV infection.